Epidemiology and management of postherpetic neuralgia

Seminars in Dermatology

Volumn 15, Issue 2 SUPPL. 1, 1996, Pages 8-13

  Gershon, Anne A ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAMCICLOVIR;

ANTIVIRAL ACTIVITY; CHRONIC PAIN; CLINICAL FEATURE; DYSESTHESIA; HEALTH CARE COST; HERPES ZOSTER; HUMAN; INCIDENCE; POSTHERPETIC NEURALGIA; REVIEW; SKIN ALLERGY;

ADULT; HERPES ZOSTER; HUMANS; MIDDLE AGED; NEURALGIA;

EID: 0029978470     PISSN: 0278145X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hope-Simpson RE: The nature of herpes zoster: A long-term study and a new hypothesis. Proc R Soc Med 58:9-20, 1965
2. Frengley JD: Herpes Zoster: A challenge in management. Primary Care 8:715-731, 1981
3. Gelb LD: Varicella zoster virus infections. Curr Opin Infect Dis 2:256-261, 1989
4. Strommen GL, Pucino F, Tight RR, et al: Human infection with herpes zoster: Etiology, pathophysiology, diagnosis, clinical course, and treatment. Pharmacotherapy 8:52-68, 1988
5. Rogers RS, Tindall JP: Geriatric herpes zoster. J Am Geriatr Soc 19:495-503, 1971
6. Portenoy RK, Duma C, Foley KM: Acute herpetic and postherpetic neuralgia: Clinical review and current management. Ann Neurol 20:651-664, 1986
7. Ragozzino MW, Melton KJ, Kurland LT, et al: Population-based study of herpes zoster and its sequelae. Medicine 61:310-316, 1982
8. Rowbotham MC, Fields HL: Post-herpetic neuralgia: The relation of pain complaint, sensory disturbance, and skin temperature. Pain 39:129-144, 1989
9. Watson PN, Evans RJ: Postherpetic neuralgia: A review. Arch Neurol 43:836-840, 1986
10. Gilden D, Rozenman Y, Murray R, et al: Detection of varicella-zoster virus nucleic acid neurons of normal human thoracic ganglia. Ann Neurol 22:337-380, 1987
11. Croen KD, Ostrove JM, Dragovic LY, et al: Patterns of gene expression and sites of latency in human ganglia are different for varicella-zoster and herpes simplex viruses. Proc Soc Nat Acad Sci 85:9773-9777, 1988
12. Straus SE: Clinical and biological differences between recurrent herpes simplex virus and varicella-zoster virus infections. JAMA 262:3455-3458, 1989
13. Bennett GJ: Hypotheses on the pathogenesis of herpes zoster-associated pain. Varicella-zoster virus infection: New insights into pathogenesis and post-herpetic neuralgia. Workshop proceedings. Ann Neurol 35:S38-41, 1994 (suppl S1)
14. Schon F, Mayer HL, Kelly JS: Pathogenesis of post-herpetic neuralgia. Lancet 2:366-368, 1987
15. deMoragas JM, Kierland RR: The outcome of patients with herpes zoster. Arch Dermatol 75:193-196, 1957
16. Tyring S, Barbarash R, Nahlik J, et al: Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia. Ann Intern Med 123:89-96, 1995
17. Whitley RJ, Straus SE: Therapy for varicella-zoster virus infections: Where do we stand? Infect Dis Clin Pract 2:100-108, 1993
18. Watson CPN, Evans RJ, Reed K, et al: Amitriptyline versus placebo in postherpetic neuralgia. Neurology 32:671-673, 1982
19. Killian JM, Fromm GH: Carbamazepine with treatment of neuralgia. Arch Neurol 19:129-136, 1968
20. Taub A: Relief of postherpetic neuralgia with psychotropic drugs. J Neurosurg 39:235-239, 1973
21. Straus SE, Ostrove JM, Inchauspe G, et al: Varicella-zoster virus infections: Biology, natural history, treatment, and prevention. Ann Intern Med 108:221-237, 1988
22. Wood MJ, Johnson RW, McKendrick MW, et al: A randomized trial of acyclovir for 7 to 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 330:896-900, 1994
23. Rowbotham MC, Fields H: Topical lidocaine reduces pain in post-herpetic neuralgia: Efficacy and pharmacokinetic profile. Pain 38:297-301, 1989
24. Watson C, Evans R, Watt V: Postherpetic neuralgia and topical capsaicin. Pain 33:333-340, 1988
25. Bernstein JE. Korman NJ, Beckers DR, et al: Topical capsaican treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 21:265-270, 1989
26. Huff JC, Bean B, Balfour HH, et al: Therapy of herpes zoster with oral acyclovir. Am J Med 85:84-89, 1988 (suppl 2A)
27. McKendrick MW, McGill JI, Wood MJ: Lack of effect of acyclovir on postherpetic neuralgia. Br Med J 298:431, 1989
28. Weller S, Blum MR, Doucette M, et al: Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 54:595-605, 1993
29. Beutner K, Friedman DJ, Forszpaniak C, et al: Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39:1546-1553, 1995
30. VALTREX Physicians' Desk Reference (ed 50). Montvale, NJ, Medical Economics Data, 1996, pp A105-A106 (suppl A)
31. Pue MA, Benet LZ: Pharmacokinetics of famciclovir in man. Antiviral Chem Chemother 4:47-55, 1993 (suppl 1)
32. Bacon TH, Gilbart J, Howard BA, et al: Inhibition of varicella-zoster virus by penciclovir in cell culture and mechanism of action. Antiviral Chem Chemother 7:71-78, 1996
33. Sacks SL, Bebault GM, Rennie BA, et al: Virus-specified phosphorylation of penciclovir in a human Schwannoma continuous cell line infected with varicella virus. Poster presented at the 34th ICAAC conference in Orlando, FL, October 1994